Among underserved and minority children with high-risk asthma, remote therapeutic monitoring was deemed feasible and met with satisfied feelings, according to results published in Annals of Allergy, Asthma & Immunology.“Patients and families find [remote therapeutic monitoring] useful, but they face barriers accessing both medication and technology, such as pharmacy refill issues and
